Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 2/2016

01.06.2016 | Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Incontinence, Voiding Dysfunction, and Other Urologic Complications After Radiotherapy for Gynecologic Malignancies

verfasst von: Garrick Greear, Carolyn Lefkowits, Lisa M. Parrillo, Brian J. Flynn

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Women with newly diagnosed gynecologic cancer will undergo treatment with surgery, radiation, or combination therapy. A considerable proportion of these women will develop urologic complications including urinary incontinence, urinary retention, radiation cystitis, ureteral stricture, or genitourinary fistula. Diagnosis is typically made with a careful history, physical exam, endoscopy, urodynamics, and imaging. Non-surgical and surgical management of urologic complications following radiotherapy is complicated by local tissue damage resulting in inferior success rates when compared to the general population. It is imperative that the patient and physician understand the complexity of treatment and manage expectations accordingly.
Literatur
1.•
Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(2):159–63. doi:10.​1007/​s00192-008-0755-z. Study using validated questionnaires that shows worse LUTD in irradiated patients.
2.
3.
Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92(3):744–51. doi:10.​1016/​j.​ygyno.​2003.​11.​048.CrossRefPubMed
4.
Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet. 2000;355(9213):1404–11. doi:10.​1016/​S0140-6736(00)02139-5.CrossRefPubMed
5.
Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375(9717):816–23. doi:10.​1016/​S0140-6736(09)62163-2.CrossRefPubMed
6.
7.
8.
9.
Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;73.2:177–83. doi:10.​1006/​gyno.​1999.​5387.CrossRef
10.
Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38(3):352–7.CrossRefPubMed
11.
12.
13.
Berek JS, Hacker NF. Gynecologic oncology. 6th ed. Philadelphia: Wolters Kluwer; 2015.
14.
15.
Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–14.CrossRefPubMed
16.
Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, Hasenburg A, Sehouli J, Habermann A, Hillemanns P, Fuerst S. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Ntnl Cancer Inst. 2015: 107.3. doi:10.​1093/​jnci/​dju426.
17.
18.
19.
20.
Kuettel MR, Parda DS, Harter WK, Rodgers JE, Lynch JH. Treatment of female urethral carcinoma in medically inoperable patients using external beam irradiation and high dose rate intracavitary brachytherapy. J Urol. 1997;157(5):1669–71.CrossRefPubMed
21.
Dalbagni G, Donat SM, Eschwege P, Herr HW, Zelefsky MJ. Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra. J Urol. 2001;166(5):1759–61.CrossRefPubMed
22.
Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, et al. Management of advanced primary urethral carcinomas. BJU Int. 2014;114(1):25–31.CrossRefPubMed
23.
Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra results of radiation therapy. Cancer. 1993;71(10):3102–8.CrossRefPubMed
24.
Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, et al. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol. 2015;136(3):521–8.CrossRefPubMed
25.
26.
27.
28.
29.
Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73(5):1501–9.CrossRefPubMed
30.••
Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29(13):1692–700. Randomized controlled trial showing increased LUTD in irradiated patients, specifically increased incontinence.
31.
Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257–80.CrossRefPubMed
32.
Perez CA, Brady LW (Eds.), Principles and practice of radiation oncology (3rd ed.), Lippincott-Raven, Philadelphia. 1998: 1733–1834.
33.
Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55(2):206–10.CrossRefPubMed
34.
Antonakopoulos GN, Hicks RM, Berry RJ. The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol. 1984;143(2):103–16.CrossRefPubMed
35.
Thiruchelvam N, Cruz F, Kirby M, Tubaro A, Chapple C, Sievert KD. A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. BJU Int. 2015;116(6):853–61. doi:10.​1111/​bju.​13078.CrossRefPubMed
36.
37.••
de Boer SM, Nout RA, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, et al. Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial. Int J Radiat Oncol Biol Phys. 2015;93(4):797–809. doi:10.​1016/​j.​ijrobp.​2015.​08.​023. Randomized controlled trial showing OAB and incontinence in patients treated with both EBRT and brachytherapy.
38.
Herwig R, Bruns F, Strasser H, Pinggera GM, Micke O, Rehder P, et al. Late urologic effects after adjuvant irradiation in stage I endometrial carcinoma. Urology. 2004;63(2):354–8.CrossRefPubMed
39.•
Wein AJ. Pathophysiology and classification of lower urinary tract dysfunction. 11th ed. Philadelphia: Elsevier; 2016. p. 1685–96. Describes established classification system for incontinence.
40.
Parkin DE, Davis JA, Symonds RP. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol. 1988;61(3):213–7.CrossRefPubMed
41.
Katepratoom C, Manchana T, Amornwichet N. Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy. Int Urogynecol J. 2014;25(1):91–6. doi:10.​1007/​s00192-013-2151-6.CrossRefPubMed
42.
Lin HH, Sheu BC, Lo MC, Huang SC. Abnormal urodynamic findings after radical hysterectomy or pelvic irradiation for cervical cancer. Int J Gynecol Obstet. 1998;63(2):169–74.CrossRef
43.
Gilbaz E, Gungor UF, Aslay I, Yalcin O. The effects of simple and radical hysterectomy and radiotherapy on lower urinary tract symptoms and urodynamics. Eur J Gynaecol Oncol. 2012;34(3):248–53.
44.
45.
Flores D, Mock S, Broghammer JA, Griebling TL, Dmochowski RR, Padmanabhan P. Onabotulinumtoxin A in patients with a history of prior pelvic radiation therapy. Annual Society of Female Urology and Urodynamics, Scottsdale, AZ, February 2015 and Annual American Urologic Association meeting, New Orleans. 2015.
46.
Flynn BJ, Yap WT. Pubovaginal sling using allograft fascia lata versus autograft fascia for all types of stress urinary incontinence: 2-year minimum followup. J Urol. 2002;167(2):608–12.CrossRefPubMed
47.
Thomas K, Venn SN, Mundy AR. Outcome of the artificial urinary sphincter in female patients. J Urol. 2002;167(4):1720–2.CrossRefPubMed
48.
Angioli R, Penalver M, Muzii L, Mendez L, Mirhashemi R, Bellati F, et al. Guidelines of how to manage vesicovaginal fistula. Crit Rev Oncol/Hematol. 2003;48(3):295–304.CrossRef
49.
Zoubek J, McGuire EJ, Noll F, DeLancey JO. The late occurrence of urinary tract damage in patients successfully treated by radiotherapy for cervical carcinoma. J Urol. 1989;141(6):1347–9.PubMed
50.
Narayanan P, Nobbenhuis M, Reynolds KM, Sahdev A, Reznek RH, Rockall AG. Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics. 2009;29(4):1073–83.CrossRefPubMed
51.
Abrams, P., De Vries, C., Elneil, S., Emasu, A., Esegbono, G., Gueye, S., Mohammad, R., Mourad, S., Hilton, P., Pickard, R., Stanford, E.. Fistula: In Abrams P, Cardozo L, Khoury S, Wein A (Eds.): Incontinence: Proceedings from the 5th International Consultation on Incontinence. Plymouth UK: Health Publications, 2013, pp.1529-1568
52.•
Pshak T, Nikolavsky D, Terlecki R, Flynn BJ. Is tissue interposition always necessary in transvaginal repair of benign, recurrent vesicovaginal fistulae? Urology. 2013;82(3):707–12. doi:10.​1016/​j.​urology.​2013.​03.​076. Retrospective review discussing need for tissue interposition in vesicovaginal fistula repair.
53.
54.
McLntyre JF, Eifel PJ, Levenback C, Oswald MJ. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995;75(3):836–43.CrossRef
55.
Windsperger A, Larke R, Higuchi T, Maroni P, Flynn B. PD3-09 ureteral reconstruction or benign stricture disease: a single institution 11 year experience with simple and complex reconstructive techniques. J Urol. 2014;4(191), e23.CrossRef
56.
Cochrane JP, Yarnold JR, Slack WW. The surgical treatment of radiation injuries after radiotherapy for uterine carcinoma. Br J Surg. 1981;68(1):25–8.CrossRefPubMed
57.
Wilkin M, Horwitz G, Seetharam A, Hartenbach E, Schink JC, Bruskewitz R, Jarrard DF. Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation. In Urologic Oncology: Seminars and Original Investigations 2005; 23(1): 12–15. Elsevier.
58.
Kisner CD, Kesner KM. Use of the transverse colon conduit for vesicovaginal fistula in late‐stage carcinoma of the cervix. Br J Urol. 1987;59(3):234–8.CrossRefPubMed
59.
Maier U, Ehrenbock PM, Hofbauer J. Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas: a retrospective analysis of 10,709 patients. J Urol. 1997;158(3):814–7.CrossRefPubMed
60.
Arai T, Nakano T, Fukuhisa K, Kasamatsu T, Tsunematsu R, Masubuchi K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer. 1991;67(2):398–405.CrossRefPubMed
61.
Duncan RE, Bennett DW, Evans AT, Aron BS, Schellhas HF. Radiation-induced bladder tumors. J Urol. 1977;118(1):43–5.PubMed
Metadaten
Titel
Incontinence, Voiding Dysfunction, and Other Urologic Complications After Radiotherapy for Gynecologic Malignancies
verfasst von
Garrick Greear
Carolyn Lefkowits
Lisa M. Parrillo
Brian J. Flynn
Publikationsdatum
01.06.2016
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 2/2016
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-016-0354-7

Weitere Artikel der Ausgabe 2/2016

Current Bladder Dysfunction Reports 2/2016 Zur Ausgabe

Voiding Dysfunction Evaluation (C Gomez, Section Editor)

Evaluation and Management of Mid-Urethral Sling Complications

Pelvic Pain (R Moldwin and S Bahlani, Section Editors)

Neuromodulation for Pelvic Pain and Sexual Dysfunction

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

An Outcomes Review of Minimally Invasive Transurethral Convective Water Vapor Energy (WAVE) Therapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Aquablation™: Early Clinical Results

Pelvic Pain (R Moldwin and S Bahlani, Section Editors)

The Role of Urinary Diversion for Bladder Pain

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Management of End-Stage Radiation Cystitis in the Cancer Survivor

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise